Case Report

At a minimum the questions following the case must be addressed in the written analysis and be no more than three printed pages plus any tables or exhibits. Answers that reflect creative thinking beyond these issues will be rewarded. Papers should be printed, double-spaced, with normal margins. The name of the case should be on the first page of the text with your names, date, and course number. An executive summary is neither required nor expected.

The page limit for each paper is three pages of text plus exhibits. Note that these are maxi­mum limits. Papers should be concise and coherent. Exhibits should contain specific types of analyses (e.g., application of a framework, table of comparisons, cost analysis, and competitive features) and information (e.g., web page of firm) that supports and is relevant, but would be too detailed for the body of the paper.

Please follow the instructions regarding the format for the case report. The report should be in a narrative (essay) form and not a Q&A form. The Questions at the end of each case are to be treated as a guideline for the issues raised in the case, and are just answering them is by no means considered a comprehensive analysis of the case.)

Case question

  1. No one was ever made ill or harmed by the fake apple juice. Was LiCari overreacting?
  2. Did LiCari follow the lines of authority in his efforts? Is this important for a whistleblower? Why?
  3. What pressures contributed to Beech-Nut’s unwillingness to switch suppliers?
  4. Using the various models for analysis of ethical dilemmas that you have learned, point out the things that Lavery, Hoyvald, and others in the company failed to consider as they refused to deal with the Interjuice problem.
  5. Why did LiCari feel he had to leave Beech-Nut? Why did LiCari write anonymously to the FDA?
  6. Is it troublesome that Hoyvald and Lavery escaped sentences on a technicality? Is the sentence too light?
  7. Why do you think Hoyvald and the others thought they could get away with the adulterated juice? Why did they play the “cat-and-mouse” game with the FDA? What principles about ethics have you learned that might have helped them analyze their situation more carefully and clearly? Are there some ideas for your credo from both their decisions and LiCari’s actions?
  8. Beech-Nut’s market share went from 19.1% of the market to 15.8%, where it has hovered ever since. Why? What were the costs of Beech-Nut’s fake apple juice and its “cat-and-mouse game”? Do you think consumers still remember this conduct?